[{"Assets_0_Q2_USD":15151000.0,"CommonStockSharesOutstanding_0_Q2_shares":28791504.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-1927000.0,"NetIncomeLoss_1_Q2_USD":-3777000.0,"NetIncomeLoss_2_Q2_USD":-18610000.0,"StockholdersEquity_0_Q2_USD":-23438000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":0.0,"Ticker":"OCGN","CIK":"1372299","name":"HISTOGENICS CORP","OfficialName":"Ocugen Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"583661968.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180809"}]